HPGLP - Overview: Hereditary Paraganglioma/Pheochromocytoma Panel, Varies

Evaluating patients with a personal or family history suggestive of a hereditary paraganglioma and pheochromocytoma (PGL/PCC) syndrome Establishing a diagnosis of a hereditary PGL/PCC, allowing for targeted surveillance based on...

BRTP - Overview: Rapid Hereditary Breast Cancer Treatment Decision Panel, Varies

Establishing a diagnosis of a hereditary breast cancer syndrome allowing for surgical and management decision making Determining therapeutic eligibility with poly (adenosine diphosphate-ribose) polymerase inhibitors based on certain gene...

MPSQU - Overview: Mucopolysaccharides Quantitative, Random, Urine

Supporting the biochemical diagnosis of one of the mucopolysaccharidoses: types I, II, III, IV, VI, or VII

AMIO - Overview: Amiodarone, Serum

Monitoring amiodarone therapy, especially when amiodarone is coadministered with other drugs that may interact Evaluating possible amiodarone toxicity Assessing patient compliance

BIWB - Overview: Bismuth, Blood

Determining bismuth toxicity

CRUO - Overview: Chromium Occupational Exposure, Random, Urine

Screening for occupational exposure

ETGC - Overview: Ethyl Glucuronide Confirmation, Random, Urine

Monitoring abstinence in clinical and justice system settings

THCU - Overview: Delta-8 and Delta-9-Carboxy-Tetrahydrocannabinol (THC) Confirmation, Random, Urine

Detection and confirmation of drug use of cannabis/marijuana and to specifically identify and quantify delta-8-carboxy tetrahydrocannabinol (THC-COOH) and delta-9-THC-COOH

DXPIN - Overview: Doxepin and Nordoxepin, Serum

Monitoring doxepin therapy Evaluating potential doxepin toxicity Evaluating patient compliance

PDSU - Overview: Drug Screen, Prescription/Over the Counter, Random, Urine

Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is not...

DESPR - Overview: Desipramine, Serum

Monitoring serum concentration of desipramine during therapy Evaluating potential desipramine toxicity May aid in evaluating patient compliance

ALC - Overview: Ethanol, Blood

Detection of ethanol (ethyl alcohol) in blood to document prior consumption or administration of ethanol Quantification of the concentration of ethanol in blood correlates directly with degree of intoxication This test is not intended for...

COKEU - Overview: Cocaine and Metabolite Confirmation, Random, Urine

Detecting and confirming drug abuse involving cocaine This test is not intended for employment-related testing.

CLD18 - Overview: Claudin 18 (CLDN18) (43-14A), Semi-Quantitative Immunohistochemistry, Manual

Identification of tumor cells expressing claudin 18 As an aid in screening patients who may be eligible for VYLOY (zolbetuximab) treatment

BRUTA - Overview: Brucella Total Antibody Confirmation, Agglutination, Serum

Diagnosis of brucellosis

ITCON - Overview: Itraconazole, Serum

Verifying systemic absorption of orally administered itraconazole Patients with life-threatening fungal infections Patients considered at risk for poor absorption or rapid clearance of itraconazole

KINM - Overview: Ki-67(MIB-1), Gastrointestinal/Pancreatic Neuroendocrine Tumors, Quantitative Immunohistochemistry, Manual

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with neuroendocrine tumors of the pancreas or gastrointestinal tract including metastases

MPHNU - Overview: Methylphenidate and Metabolite, Random, Urine

Monitoring urine methylphenidate and ritalinic acid concentrations to assess compliance in patients

KIPM - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Manual

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases, using a manual method

HYDMU - Overview: Hydromorphone Confirmation, Random, Urine

Detection and quantification of hydromorphone in urine

HYDCU - Overview: Hydrocodone with Metabolite Confirmation, Random, Urine

Detection and quantification of hydrocodone, norhydrocodone, and hydromorphone in urine

FIBAG - Overview: Fibrinogen Antigen, Plasma

Evaluation of fibrinogen deficiency Measuring fibrinogen in patients with elevated plasma levels of fibrin degradation products, patients receiving heparin, and in patients with antibodies to thrombin (following surgical use of topical...

FL - Overview: Fluoride, Plasma

Assessing accidental fluoride ingestion Monitoring patients receiving sodium fluoride for bone disease or patients receiving voriconazole therapy

FENS - Overview: Fentanyl Screen, Random, Urine

Screening for drug abuse or use involving fentanyl

GABA - Overview: Gabapentin, Serum

Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients

NAACD - Overview: N-Acetylaspartic Acid, Canavan Disease, Random, Urine

Diagnosis and monitoring of individuals with Canavan disease Follow-up quantitation of abnormal organic acid elevations of N-acetylaspartic acid

NOTRP - Overview: Nortriptyline, Serum

Monitoring nortriptyline concentration during therapy Evaluating potential nortriptyline toxicity May aid in evaluating patient compliance

HGCU - Overview: Mercury/Creatinine Ratio, Random, Urine

Detecting mercury toxicity using random urine specimens

PINW - Overview: Pinworm Exam, Perianal

Detection of the eggs of Enterobius vermicularis on the skin of the perianal folds

SAT - Overview: Percent Saturation

Calculation of percent saturation

POSA - Overview: Posaconazole, Serum

Monitoring posaconazole therapy

TLB - Overview: Thallium, Blood

Detecting toxic exposure in whole blood specimens

THEO - Overview: Theophylline, Serum

Assessing and adjusting theophylline dosage for optimal therapeutic level Assessing theophylline toxicity

TAKRO - Overview: Tacrolimus, Blood

Monitoring whole blood tacrolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...

TRMP - Overview: Trimipramine, Serum

Monitoring trimipramine concentration during therapy Evaluating potential trimipramine toxicity May aid in evaluating patient compliance

TOPI - Overview: Topiramate, Serum

Monitoring serum concentrations of topiramate Assessing compliance Assessing potential toxicity

VITE - Overview: Vitamin E, Serum

Monitoring of Vitamin E supplementation/treatment Potentially detecting Vitamin E overdoses

FLUC - Overview: 5-Flucytosine, Serum

Monitoring serum concentration during therapy Evaluating potential toxicity May aid in evaluating patient compliance

VLTU - Overview: Volatile Screen, Random, Urine

Detecting the presence of acetone, methanol, isopropanol, or ethanol in urine with subsequent quantitation

FLEC - Overview: Flecainide, Serum

Optimizing flecainide dosage Assessing flecainide toxicity Monitoring compliance

MEX - Overview: Mexiletine, Serum

Assessing achievement of optimal therapeutic mexiletine concentrations Assessing potential mexiletine toxicity

LEVE - Overview: Levetiracetam, Serum

Monitoring serum concentration of levetiracetam, particularly in patients with kidney disease Assessing compliance with levetiracetam therapy Assessing potential toxicity of levetiracetam

FELBA - Overview: Felbamate (Felbatol), Serum

Determining whether a poor therapeutic response is attributable to noncompliance or lack of drug effectiveness Monitoring changes in serum concentrations resulting from interactions with coadministered drugs such as barbiturates and...

PFN - Overview: Propafenone, Serum

Monitoring propafenone therapy Assessing potential propafenone toxicity

ADEVL - Overview: Alzheimer Disease Evaluation, Spinal Fluid

Assessment of adults with cognitive impairment being evaluated for Alzheimer disease and other causes of cognitive impairment These assays should not be used to predict the development of dementia or other neurologic conditions or to...

SCCNP - Overview: Severe Congenital and Cyclic Neutropenia Gene Panel, Varies

Providing a genetic evaluation for patients with a personal or family history suggestive of severe congenital neutropenia and/or cyclic neutropenia Establishing a diagnosis of an inherited congenital neutropenia and, in some cases,...

BUPS - Overview: Buprenorphine Screen, Random, Urine

Screening for drug abuse or use of buprenorphine

AMPHU - Overview: Amphetamines Confirmation, Random, Urine

Confirming drug exposure involving amphetamines such as amphetamine and methamphetamine, phentermine, pseudoephedrine/ephedrine, methylenedioxyamphetamine (MDA), and methylenedioxymethamphetamine (MDMA)

ALPI - Overview: Alkaline Phosphatase Isoenzymes, Serum

Aid in the diagnosis and treatment of liver, bone, intestinal, and parathyroid diseases Determining the tissue source of increased alkaline phosphatase (ALP) activity in serum Differentiating between liver and bone sources of elevated...

AHPRU - Overview: Antihypertension Panel, Random, Urine

Aid in the management of hypertension, especially treatment resistant hypertension Monitoring compliance in individuals prescribed antihypertensive drug therapy As a screen for to detect nonprescribed use of common diuretics